Patients with binge eating disorder and depressive symptoms reported executive functioning deficits, even though neuropsychological tests showed no significant differences in executive functioning between them and healthy controls.
Researchers have proposed a model that can explain the degree of depression in Parkinson disease, using imaging and genetics data.
An integrated collaborative care intervention resulted in modest improvements in weight loss and depressive symptoms in adults with obesity and depression.
Low field magnetic stimulation for treatment-resistant depression may have a potentially rapid onset of action with few adverse effects.
The Food and Drug Administration (FDA) has approved Zulresso (brexanolone; Sage Therapeutics) injection for the treatment of postpartum depression in adult women, the first drug to be approved for this indication. Zulresso, an analogue of the endogenous human hormone allopregnanolone, is intended for continuous intravenous (IV) infusion over 2.5 days following a titration schedule. It…
Atopic dermatitis (AD) is associated with increased depression and anxiety.
Mood reactivity and affective lability may bridge the gap between mixed and atypical depression.
Preventive strategies to reduce cannabis use among youth are needed, as adolescent cannabis consumption is associated with increased risk for depression and suicidal behavior later in life.
Cognitive behavioral therapy may improve a diverse array of depressive symptoms in patients with Parkinson disease.
Reduced fetal growth was associated with a small but significant increase in the general risk for psychiatric and neurodevelopmental disorders.